comparemela.com

Latest Breaking News On - Hirokazu yamura - Page 1 : comparemela.com

Japan focus: Daiken Biomedical s Japanese patent, B breve benefits, Meiji and Albion s collaboration, CURE s debut

This round-up features Daiken Biomedical’s Japanese patent, positive effects of probiotic strain Bifidobacterium breve M-16V, Meiji and Albion’s collaborative launch, Asahi-funded study on yeast mannan, and CBD brand CURE’s Japan debut plans.

Cüre To Launch CBD Products In Japan s New Market

Police Boss Turned Cannabis Reform Advocate, MMJ Legalization In Japan And More Global Updates - Jazz Pharmaceuticals (NASDAQ:JAZZ)

Medical Cannabis-Based Epidiolex Advances Through Japan's Legislature Earlier this week, Japanese policymakers gave the green light to a measure to legalize medical products derived from cannabis, simultaneously emphasizing the country's existing restrictions on the use of other marijuana products.

The CURE Brand To Introduce its Suite of Wellness Consumer Products to Asia

The CURE BRAND ("CURE" or the "Company"), an international lifestyle brand for the modern CBD consumer, today announced that it has entered into a joint partnership with Hirokazu Yamura, CEO of AJP Co Ltd, to introduce its portfolio of carefully sourced CBD products into retail and e-commerce marketplaces across Asia's fastest-growing market — Japan.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.